Cagri Karaciklar Benign Soft Tissue Tumors
Cagri Karaciklar Benign Soft Tissue Tumors
Cagri Karaciklar Benign Soft Tissue Tumors
16 April 2020
Etiology
Genetic conditions
Good evidence exists suggesting that certain genetic disorders and gene mutations
are predisposing factors for some benign and malignant soft-tissue tumors. The
NF1 gene in neurofibromatosis is a classic example, predisposing patients to
multiple neurofibromas with a proclivity for malignant transformation. Many tumor suppressor genes,
oncogenes, and cytogenetic defects are now associated with various soft-tissue sarcomas. Other clinical risk
factors account for a small proportion of soft tissue malignancies.
Radiation
Chronic lymphedema
Environmental carcinogens
Infection
Trauma
Lipomas
The most common benign soft tissue tumor made of fat and is usually large and soft. They are located on
the back, shoulders, abdomen and upper and lower extremities. They usually do not cause symptoms unless
they begin to push on nearby nerves. Lipomas usually grow slowly with little change over many years. Many
patients seek medical attention for cosmetic reasons when a lipoma grows too large. An angiolipoma which
involves blood vessels usually occurs in children located deep in the muscle and is tender because it involves
the vessels. On the MRI scan, the lipoma is seen as a bright, well defined mass. Treatment includes removing
(excising) the mass or observing it if it is not bothersome. Recurrences are unusual.
Hemangioma
A benign vascular (involving blood vessels) soft tissue tumor. It is the most common soft tissue tumor in
children. It can develop in the top skin (superficial) layer or deep within the muscle. They occur more often in
the lower extremities than the upper extremities. Hemangiomas can range from being well-defined,
noninvasive and involving small vessels (capillaries) to less defined, invasive and involving large vessels. The
most common type of hemangioma is made of both large and small vessels. The MRI scan is the best type
of imaging to show the location and extent of the tumor. Angiograms may also be done to evaluate the large
blood vessels.
1. Conrad EU 3rd, Bradford L, Chansky HA. Pediatric soft-tissue sarcomas. Orthop Clin North Am. 1996
Jul.
2. Ludwig JA. Personalized therapy of sarcomas: integration of biomarkers for improved diagnosis,
prognosis, and therapy selection. Curr Oncol Rep. 2008 Jul. 10
3. Ordóñez JL, Martins AS, Osuna D, Madoz-Gúrpide J, de Alava E. Targeting sarcomas: therapeutic
targets and their rational. Semin Diagn Pathol. 2008 Nov. 25
4. Dal Cin P. Soft tissue tumors: an overview. Atlas of Genetics and Cytogenetics in Oncology and
Haematology. Available at http://AtlasGeneticsOncology.org/Tumors/softissuTumID5042.html. July 2013
5. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the
Musculoskeletal Tumor Society. J Bone Joint Surg Am.